Literature DB >> 17044800

Osteonecrosis of the jaw: what do bisphosphonates do?

Per Aspenberg.   

Abstract

Osteonecrosis of the jaw is a new disease, partly caused by bisphosphonates. It is commonly assumed that the bisphosphonates somehow cause cell death (osteocyte necrosis) within the jawbone, which makes it prone to chronic infection. In this article, an alternative pathogenetic theory is suggested, based on the normal effect of bisphosphonates. According to the new theory, the bone is alive until it is injured and infected, and the reduced resorptive ability due to bisphosphonates hinders the formation of a fresh bone surface for re-establishment of bone cell coverage. The theories are compared, based on the recent, very scarce literature. None of them can be completely refuted, but the demonstration of living osteocytes within the lesion and the number of necessary assumptions speak against the theory of a primary, bisphosphonate-induced necrosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044800     DOI: 10.1517/14740338.5.6.743

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  11 in total

Review 1.  Bisphosphonate-related osteonecrosis of the jaw and dental implants.

Authors:  Ala Hassan A Qamheya; Sinem Yeniyol; Volkan Arisan
Journal:  J Istanb Univ Fac Dent       Date:  2016-01-12

Review 2.  Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis.

Authors:  Christian Powell; Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-08       Impact factor: 8.667

Review 3.  The osteocyte as a therapeutic target in the treatment of osteoporosis.

Authors:  Gaël Y Rochefort
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-06       Impact factor: 5.346

Review 4.  Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons.

Authors:  Kyoung Min Kim; Yumie Rhee; Yong-Dae Kwon; Tae-Geon Kwon; Jeong Keun Lee; Deog-Yoon Kim
Journal:  J Bone Metab       Date:  2015-11-30

Review 5.  Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment.

Authors:  Lars Rasmusson; Jahan Abtahi
Journal:  Int J Dent       Date:  2014-09-01

6.  Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.

Authors:  X Wei; S Pushalkar; C Estilo; C Wong; A Farooki; M Fornier; G Bohle; J Huryn; Y Li; S Doty; D Saxena
Journal:  Oral Dis       Date:  2012-03-23       Impact factor: 3.511

7.  Treatment of bisphosphonate induced osteonecrosis of jaw in rats using an angiogenesis factor (A-Heal) and ABMDO (Autologous Bone Marrow Derived Osteoblasts).

Authors:  Mir Sadat-Ali; Naif A AlMasoud; Tarek M Hegazi; Sadananda Acharya; Ahmed A Alsulaiman; Ayesha Ahmed; Methal I AlBayat
Journal:  Saudi Dent J       Date:  2021-12-23

Review 8.  Bisphosphonates and implants: an overview.

Authors:  Per Aspenberg
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

9.  Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking.

Authors:  Arezo Tardast; Reine Sjöman; Sigbjørn Løes; Jahan Abtahi
Journal:  J Appl Oral Sci       Date:  2015 May-Jun       Impact factor: 2.698

10.  Bisphosphonate related osteonecrosis of the jaw: a study of 18 cases associated with fungal infection.

Authors:  V Aftimos; T Zeinoun; R Bou Tayeh; G Aftimos
Journal:  Int J Dent       Date:  2014-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.